Dr Kylie Crompton
Dr Kylie Crompton is a research scientist with a background in biomaterials for regenerative medicine. She completed her PhD in tissue engineering at Monash University in 2007, was employed as Research Scientist at PolyNovo Biomaterials Pty Ltd until 2009 and then took a career break. Dr Crompton started as Research Officer at Murdoch Childrens Research Institute in 2012.
Dr Kylie Crompton is interested in repair of the nervous system through cellular delivery, tissue engineering or biomaterials. Her current focus is intravenous infusion of cord blood cells as a possible treatment for children with cerebral palsy. This is a much-hyped therapy with very little evidence to justify its use.
Dr Crompton is also interested in possible genetic origins of some forms of cerebral palsy and whether this or epigenetic analysis might act as a biomarker for cerebral palsy.
- Trial of cord blood cell infusion as a treatment for children with cerebral palsy
- Can we predict cerebral palsy at birth? Epigenetics study of twins discordant for cerebral palsy
- Gene discovery in cerebral palsy. Recruitment for international cohort, biobank
Crompton KE, Elwood N, Kirkland M, Clark P, Novak I and Reddihough D. Feasibility of trialling cord blood stem cell treatments for cerebral palsy in Australia J Paediatr Child Health 2014; doi: 10.1111/jpc.12618 [Epub ahead of print]
Li A, Dearman B, Crompton K, Moore TG and Greenwood JE. Evaluation of a novel biodegradable polymer for the generation of a dermal matrix. J Burn Care Res 2009; 30(4):717-28
Crompton KE, Forsythe JS, Horne MK, Finkelstein DI and Knott RB. Molecular and microstructural characterisation of thermally sensitive chitosan hydrogels. Soft Matter 2009; 5: 4704-11